Literature DB >> 34723254

Relationship of Vitamin D Deficiency and Fatty Liver in Children as Defined by Multiple Imaging and Histologic Endpoints.

Bryan Rudolph1, Tyler Selig2, Yingjie Li1, Nadia Ovchinsky1, Debora Kogan-Liberman1, Mark C Liszewski3, Terry Levin3, Michelle Ewart4, Qiang Liu4, Shankar Viswanathan5, Juan Lin5, Xiaonan Xue5, Robert D Burk5, Howard D Strickler5.   

Abstract

OBJECTIVES: The relationship between vitamin D deficiency (VDD) and pediatric nonalcoholic fatty liver disease (NAFLD) remains uncertain due to conflicting results and few studies with histologic endpoints. We therefore used multiple imaging and histologic NAFLD endpoints to more comprehensively assess the association between VDD and NAFLD in a large pediatric population.
METHODS: Data were obtained from an ongoing pediatric NAFLD study in Bronx, NY. Briefly, overweight and obese children aged 2-18 years with alanine aminotransferase (ALT) levels ≥ 35 U/L were serially enrolled. Liver biopsy was obtained in accordance with clinical guidelines. All participants had liver imaging, namely, controlled attenuation parameter (CAP; Echosens, France) to assess steatosis and, to assess fibrosis, vibration controlled transient elastography (VCTE; FibroScan™, Echosens, France) and acoustic radiation force impulse (ARFI; Philips, Netherlands) imaging. Levels of 25-hydroxyvitamin D were measured serologically.
RESULTS: N=276 (88%) of 315 participants had 25-OH vitamin D results, of whom 241 (87%) were Hispanic, 199 (72%) were male, and 92 (33%) underwent liver biopsy. VDD was univariately associated with high waist circumference (p=0.004), high-density lipoprotein level (p=0.01), season (p=0.009), and CAP score (p=0.01). In multivariate analysis, only waist circumference (p=0.0002) and biopsy inflammation grade (p=0.03) were associated with VDD, though the latter had not approximated statistical significance in univariate analysis (p=0.56). There was no association between VDD and hepatic steatosis, ballooning, NAFLD Activity Score, ARFI or VCTE elasticity scores.
CONCLUSIONS: VDD was not associated with NAFLD defined by imaging and histologic endpoints, except for a possible relation with histologic inflammation grade.

Entities:  

Keywords:  Children; Elastography; Nonalcoholic Steatohepatitis; Vitamin D

Year:  2021        PMID: 34723254      PMCID: PMC8553135          DOI: 10.1097/PG9.0000000000000077

Source DB:  PubMed          Journal:  JPGN Rep        ISSN: 2691-171X


  41 in total

1.  Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease.

Authors:  Mohammad S Siddiqui; Raj Vuppalanchi; Mark L Van Natta; Erin Hallinan; Kris V Kowdley; Manal Abdelmalek; Brent A Neuschwander-Tetri; Rohit Loomba; Srinivasan Dasarathy; Danielle Brandman; Edward Doo; James A Tonascia; David E Kleiner; Naga Chalasani; Arun J Sanyal
Journal:  Clin Gastroenterol Hepatol       Date:  2018-04-26       Impact factor: 11.382

2.  Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats.

Authors:  Shirley Abramovitch; Liora Dahan-Bachar; Efrat Sharvit; Yosef Weisman; Amir Ben Tov; Eli Brazowski; Shimon Reif
Journal:  Gut       Date:  2011-08-04       Impact factor: 23.059

3.  Vitamin D levels and bone turnover markers are not related to non-alcoholic fatty liver disease in severely obese patients.

Authors:  Rubén Díez Rodríguez; María D Ballesteros Pomar; Alicia Calleja Fernández; Sara Calleja Antolin; Isidoro Cano Rodríguez; Pedro Linares Torres; Francisco Jorquera Plaza; José Luis Olcoz Goñi
Journal:  Nutr Hosp       Date:  2014-12-01       Impact factor: 1.057

Review 4.  Changes in circulating vitamin D levels with loss of adipose tissue.

Authors:  Anne Gangloff; Jean Bergeron; Isabelle Lemieux; Jean-Pierre Després
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2016-11       Impact factor: 4.294

5.  Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus.

Authors:  Ilaria Barchetta; Simone Carotti; Giancarlo Labbadia; Umberto Vespasiani Gentilucci; Andrea Onetti Muda; Francesco Angelico; Gianfranco Silecchia; Frida Leonetti; Antonio Fraioli; Antonio Picardi; Sergio Morini; Maria Gisella Cavallo
Journal:  Hepatology       Date:  2012-12       Impact factor: 17.425

6.  Comparison of Controlled Attenuation Parameter and Liver Biopsy to Assess Hepatic Steatosis in Pediatric Patients.

Authors:  Nirav K Desai; Sarah Harney; Roshan Raza; Alyaa Al-Ibraheemi; Nick Shillingford; Paul D Mitchell; Maureen M Jonas
Journal:  J Pediatr       Date:  2016-03-30       Impact factor: 4.406

7.  Prevalence and correlates of suspected nonalcoholic fatty liver disease in Chinese American children.

Authors:  Miguel Malespin; Brett Sleesman; Alan Lau; Shirley S Wong; Scott J Cotler
Journal:  J Clin Gastroenterol       Date:  2015-04       Impact factor: 3.062

8.  Role of vitamin D in children with hepatosteatosis.

Authors:  Ismail Yildiz; Oguz B Erol; Sadik Toprak; Mustafa S Cantez; Beyhan Omer; Ayse Kilic; Fatma Oguz; Metin Uysalol; Ensar Yekeler; Emin Unuvar
Journal:  J Pediatr Gastroenterol Nutr       Date:  2014-07       Impact factor: 2.839

9.  Prospective comparison among transient elastography, supersonic shear imaging, and ARFI imaging for predicting fibrosis in nonalcoholic fatty liver disease.

Authors:  Myoung Seok Lee; Jeong Mo Bae; Sae Kyung Joo; Hyunsik Woo; Dong Hyeon Lee; Yong Jin Jung; Byeong Gwan Kim; Kook Lae Lee; Won Kim
Journal:  PLoS One       Date:  2017-11-27       Impact factor: 3.240

10.  The diagnostic accuracy of liver fibrosis in non-viral liver diseases using acoustic radiation force impulse elastography: A systematic review and meta-analysis.

Authors:  Yuanqiang Lin; Hequn Li; Chunxiang Jin; Hui Wang; Bo Jiang
Journal:  PLoS One       Date:  2020-01-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.